Naoi et al. analyzed 576 cases of de novo DLBCL and identified different IHC CD79b staining patterns, with the majority being cytoplasmic (75%), membranous (14.9%), and 9% negative cases. This evidence concerns the gene CD79B and diffuse large B-cell lymphoma.